Navigation Links
Mayo Clinic study continues to refine most effective methods to predict Alzheimer's disease
Date:7/14/2009

ROCHESTER, Minn. -- A new Mayo Clinic study found that the clinical criteria for mild cognitive impairment is better at predicting who will develop Alzheimer's disease than a single memory test. This is one more piece of information to aid in the identification and early treatment of individuals most likely to develop Alzheimer's disease. This study will be presented at the Alzheimer's Association International Conference on Alzheimer's Disease on July 14 in Vienna.

Alzheimer's disease is a degenerative disorder of the brain in which nerve cells die over time, resulting in a steady loss of memory and other thinking abilities. An estimated 5.3 million Americans are living with Alzheimer's disease, and it is the sixth-leading cause of death in the U.S. Mild cognitive impairment is a transitional state between normal aging and the earliest features of Alzheimer's disease.

"The goal of this research is to try to predict who is going to develop Alzheimer's disease in the future," says Ronald Petersen, M.D., Ph.D., a neurologist at Mayo Clinic and the lead author of this study. "Ideally, we'd like to identify individuals before any damage is done in the brain. The sooner we intervene on this process with medications or other therapies, the greater impact we can have on lessening the number of people who will ultimately develop Alzheimer's disease."

Dr. Petersen and his team studied 1,261 individuals aged 70󈟅 years who were cognitively normal or had only slight memory impairment at the onset of the study. The individuals were followed for up to 10 years. Scores on a memory test and the clinical criteria for mild cognitive impairment (including a memory test as well as other assessments of cognitive function) were studied as possible predictors for eventual development of Alzheimer's disease. The team found that the clinical criteria for mild cognitive impairment was better able to predict who was going to develop Alzheimer's disease in the future.

"As the baby boomers age into the period of risk for Alzheimer's disease, we're talking about a significant number of individuals who may become cognitively impaired in the very near future," says Dr. Petersen. "Consequently, we need information like this about the best methods of early prediction so that we can develop therapies to prevent or treat the condition and avoid being overwhelmed by the burden of these individuals on the health care system."


'/>"/>

Contact: Karl Oestreich
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Mayo Clinic Study Continues to Refine Most Effective Methods to Predict Alzheimers Disease
2. New Medical Imaging Organization Launched to Represent Industry Personnel and Diagnostic Clinics
3. DaVita Clinical Research Appoints Mahesh Krishnan as Vice President
4. Promising hematologists begin year-long program to pursue careers in clinical research
5. 2009 recipient of minority scholar award begins clinical research on leukemia
6. Cleveland Clinic Lou Ruvo Center for Brain Health Opens for Business
7. Patient Enrollment Complete for Phase I/II Clinical Trial for GALNS for Morquio A Syndrome
8. Analysis of Four Large Post-Marketing Surveillance Studies Describe Clinical Effects of Sucrose-Formulated Recombinant Factor VIII
9. Three New Studies Give Clear Guidance on How to Better Recruit Volunteers for Alzheimers Clinical Studies
10. Mayo Clinic study using structural MRI may help accurately diagnose dementia patients
11. Mayo Clinic Study Using Structural MRI May Help Accurately Diagnose Dementia Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... 2017 , ... Peoples Health is pleased to announce that ... 1, 2016. Peoples Health, a Metairie-based Medicare Advantage company, serves more than 55,000 ... our provider network, and the addition will benefit our members in the Greater ...
(Date:1/17/2017)... NJ (PRWEB) , ... January 17, 2017 , ... Neil ... and financial planning assistance to communities throughout the region, is launching a charity drive ... Heart disease is by far the deadliest killer in America, and is responsible for ...
(Date:1/17/2017)... ... January 17, 2017 , ... Seceon ... cyber threats in real-time, today announced a strategic partnership with TechLab Security, ... Joining other Seceon partners, TechLab Security has become a strategic partner and a ...
(Date:1/17/2017)... CA (PRWEB) , ... January 17, 2017 , ... Many people make New Year’s resolutions ... Robert Mondavi is making it easier for people who want to kick off ... both new and existing patients. , These special offers include: , ...
(Date:1/16/2017)... ... January 17, 2017 , ... Recently, patients and staff ... Michigan, joined other volunteers and organizations in support of the annual Binder Park Zoo ... families dressed up in colorful costumes of all designs coming out to enjoy games, ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... Calif. , Jan. 17, 2017  Edwards Lifesciences ... in patient-focused innovations for structural heart disease and critical ... the quarter ended December 31, 2016 after the market ... a conference call at 5:00 p.m. ET that day ... the conference call, dial (877) 407-8037 or (201) 689-8037.  ...
(Date:1/17/2017)... PUNE, India , Jan. 17, 2017  Market Research Future ... Global Endoscopy Devices Market is expected to reach USD 33.6 million ... 2016. Market Highlights ... The Global Endoscopy Devices Market has been examined as ... rate. Globally there is huge demand for endoscopy device in various ...
(Date:1/17/2017)... Research and Markets has announced the addition of the ... offering. ... global fluoropolymer market in the healthcare industry to grow at a ... Fluoropolymer Market in the Healthcare Industry 2016-2020, has been prepared based ... report covers the market landscape and its growth prospects over the ...
Breaking Medicine Technology: